ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,319.20
      2.45%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      73.98
      -0.46%
      Bitcoin
      62,995.19
      0.07%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pacira BioSciences Inc (PCRX)

      7. Pacira BioSciences Inc (PCRX) Financials

      Pacira BioSciences Inc

      Pacira BioSciences Inc (PCRX)

      PharmaCorp RX Inc
      14.69
      0.04
      (0.27%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      14.69
      0.00
      (0.00%)
      After Hours: 7:00PM
      Delayed by 15 minutes

      Pacira BioSciences Inc Financial Summary

      The current PCRX market cap is 677.6M. The company's latest EPS is USD 0.9096 and P/E is 16.16.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 173.97M160.57M183.52M170.92M176.51M
      Operating Income 39.88M17.72M33.17M13.21M28.24M
      Net Income 25.76M10.86M24.87M8.98M18.89M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 421.03M429.65M541.53M666.82M678.4M
      Operating Income 10.48M46.35M89.92M60.02M87.68M
      Net Income -11.02M145.52M41.98M15.91M41.96M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.54B1.53B1.57B1.58B1.65B
      Total Liabilities 734.41M702.91M704.26M691.16M767.54M
      Total Equity 807.98M831.55M870.13M892.16M879.28M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 831.07M1.27B2.08B1.68B1.57B
      Total Liabilities 476.12M654.83M1.34B906.19M704.26M
      Total Equity 354.94M619.69M730.41M775.01M870.13M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 62.63M107.07M154.65M49.1M102.34M
      Investing 73.51M69.17M77.54M-15.53M-30.75M
      Financing -153.47M-181.25M-183.03M-2.82M22.16M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 70.52M77.03M125.72M145.27M154.65M
      Investing -128.49M-277.61M-20.79M-225.19M77.54M
      Financing 3.67M222.3M380.69M-401.53M-183.03M

      Stats and Ratios

      Market Cap 677.6M
      Price to Earnings Ratio 16.16
      Price to Sales Ratio 1
      Price to Cash Ratio 4.42
      Price to Book Ratio 0.78
      Dividend Yield -

      Share Statistics

      Shares Outstanding 46.13M
      Average Volume (1 week) 1.17M
      Average Volume (1 Month) 1M
      52 Week Change -55.48%
      52 Week High 35.95
      52 Week Low 11.164
      Spread (Intraday) 3.21 (21.1%)

      Company Info

      Company Name Pacira BioSciences Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.pacira.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      PCRX
      Pacira BioSciences
      Delayed Upgrade Clock